Drug Giants Create Fund to Bolster Struggling Antibiotic Start-Ups New medicines are desperately needed to treat a growing number of drug-resistant infections, but many companies developing the drugs are short on cash and investments.
|
Drug Giants Create Fund to Bolster Struggling Antibiotic Start-Ups New medicines are desperately needed to treat a growing number of drug-resistant infections, but many companies developing the drugs are short on cash and investments.
|